Literature DB >> 7541940

Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents.

J M Gleadle1, B L Ebert, J D Firth, P J Ratcliffe.   

Abstract

Recent work has indicated that oxygen-sensing mechanism(s) resembling those controlling erythropoietin production operate in many non-erythropoietin-producing cells. To pursue the implication that such a system might control other genes, we studied oxygen-regulated expression of mRNAs for vascular endothelial growth factor, platelet-derived growth factor (PDGF) A and B chains, placental growth factor (PLGF), and transforming growth factor in four different cell lines and compared the characteristics with those of erythropoietin regulation. Oxygen-regulated expression was demonstrated for each gene in at least one cell type. However, the response to hypoxia (1% oxygen) varied markedly, ranging from a 13-fold increase (PDGF-B in Hep G2 cells) to a 2-fold decrease (PLGF in the trophoblastic line BeWo). For each gene/cell combination, both the magnitude and direction of the response to hypoxia were mimicked by exposure to cobaltous ions or two different iron-chelating agents, desferrioxamine and hydroxypyridinones. These similarities with established characteristics of erythropoietin regulation indicate that a similar mechanism of oxygen sensing is operating on a variety of vascular growth factors, and they suggest that chelatable iron is closely involved in the mechanism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541940     DOI: 10.1152/ajpcell.1995.268.6.C1362

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  46 in total

Review 1.  Glucose, VEGF-A, and diabetic complications.

Authors:  L E Benjamin
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 2.  Influence of hypoxia in inflammatory synovitis.

Authors:  T Bodamyali; C R Stevens; M E Billingham; S Ohta; D R Blake
Journal:  Ann Rheum Dis       Date:  1998-12       Impact factor: 19.103

3.  Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: role of hypoxia responsive element.

Authors:  A Minchenko; J Caro
Journal:  Mol Cell Biochem       Date:  2000-05       Impact factor: 3.396

Review 4.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

5.  Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia.

Authors:  H J Marti; M Bernaudin; A Bellail; H Schoch; M Euler; E Petit; W Risau
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

6.  Engineering vascularized tissues using natural and synthetic small molecules.

Authors:  Lauren S Sefcik; Caren E Petrie Aronin; Edward A Botchwey
Journal:  Organogenesis       Date:  2008-10       Impact factor: 2.500

7.  Placenta growth factor (PlGF) mRNA expression in brain tumors.

Authors:  M Nomura; S Yamagishi; S Harada; T Yamashima; J Yamashita; H Yamamoto
Journal:  J Neurooncol       Date:  1998-11       Impact factor: 4.130

Review 8.  Manipulation of neural progenitor fate through the oxygen sensing pathway.

Authors:  Yuan Xie; William E Lowry
Journal:  Methods       Date:  2017-08-31       Impact factor: 3.608

9.  The study on the relationship between serum vascular endothelial growth factor and proteinuria in adriamycin-induced nephrotic rats.

Authors:  Z Zhu; Y Wang; H Wang; A Deng
Journal:  J Tongji Med Univ       Date:  2001

10.  Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney.

Authors:  C J Ward; H Turley; A C Ong; M Comley; S Biddolph; R Chetty; P J Ratcliffe; K Gattner; P C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.